Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2024 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2024 Earnings Call Transcript May 14, 2024

Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.75276 EPS, expectations were $-0.61.

Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals First Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate...